Monday, August 28, 2006

Zogenix Raises $60M

Zogenix has raised $60M in a Series A financing, the firm announced this morning. The company received funding from Clarus Ventures and Domain Associates, along with additional investors BA Venture Partners, Thomas, McNerney & Partners, and Life Science Angels. The funding will be used in an acquisition of migraine treatment technology from Hayward, California-based Aradigm Corporation. Zogenix has purchased Aradigm's Intraject subcutaneous delivery technology to Zogenix. The firm plans to develop and commercialize the product. Zogenix has offices in San Diego and Hayward. More information »